Biocryst Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for BIOCRYST, and what generic alternatives to BIOCRYST drugs are available?
BIOCRYST has two approved drugs.
There are nine US patents protecting BIOCRYST drugs.
There are one hundred and thirty-two patent family members on BIOCRYST drugs in forty countries and twelve supplementary protection certificates in eleven countries.
Drugs and US Patents for Biocryst
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocryst | ORLADEYO | berotralstat hydrochloride | CAPSULE;ORAL | 214094-002 | Dec 3, 2020 | RX | Yes | Yes | 10,662,160 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Biocryst | ORLADEYO | berotralstat hydrochloride | CAPSULE;ORAL | 214094-002 | Dec 3, 2020 | RX | Yes | Yes | 10,689,346 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | RX | Yes | Yes | 10,391,075 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Biocryst | ORLADEYO | berotralstat hydrochloride | CAPSULE;ORAL | 214094-001 | Dec 3, 2020 | RX | Yes | No | 10,689,346 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Biocryst | ORLADEYO | berotralstat hydrochloride | CAPSULE;ORAL | 214094-002 | Dec 3, 2020 | RX | Yes | Yes | 10,125,102 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | RX | Yes | Yes | 6,562,861 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Biocryst | ORLADEYO | berotralstat hydrochloride | CAPSULE;ORAL | 214094-001 | Dec 3, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Biocryst
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Biocryst | RAPIVAB | peramivir | SOLUTION;INTRAVENOUS | 206426-001 | Dec 19, 2014 | 6,503,745 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Biocryst Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2015180695 | ⤷ Try a Trial |
Croatia | P20201916 | ⤷ Try a Trial |
Israel | 247518 | ⤷ Try a Trial |
Japan | 6915003 | ⤷ Try a Trial |
South Korea | 20210135632 | ⤷ Try a Trial |
Eurasian Patent Organization | 025483 | ⤷ Try a Trial |
Uruguay | 38438 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Biocryst Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3113772 | 21C1048 | France | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT ET SELS PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI; REGISTRATION NO/DATE: EU/1/21/1544 20210504 |
3113772 | C03113772/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68464 07.06.2022 |
3113772 | LUC00233 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT ET LES SELS PHARMACEUTIQUEMENT ACCEPTABLES QUI EN DERIVENT; AUTHORISATION NUMBER AND DATE: EU/1/21/1544 20210504 |
3113772 | CR 2021 00040 | Denmark | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT OG FARMACEUTISK ACCEPTABLE SALTE DERAF; REG. NO/DATE: EU/1/21/1544 20210504 |
3113772 | 42/2021 | Austria | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT UND PHARMAZEUTISCH ANNEHMBARE SALZE DAVON; REGISTRATION NO/DATE: EU/1/21/1544 20210504 |
3113772 | 301142 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/21/1544 20210504 |
3113772 | 122021000062 | Germany | ⤷ Try a Trial | PRODUCT NAME: BEROTRALSTAT ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1544 20210430 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.